(±)12-HEPE – 50 µg

Brand:
Cayman
CAS:
81187-21-5
Storage:
-20
UN-No:
De Minimis - 1170 / 3

(±)12-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 12(S)-HEPE and 12(R)-HEPE. The biological activity of (±)12-HEPE is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet aggregation with the same potency as 12-HETE, exhibiting IC50 values of 24 and 25 µM, respectively.{11169} These compounds are also equipotent as inhibitors of U46619-induced contraction of rat aorta (IC50s = 8.6-8.8 µM).{7481}  

 

Available on backorder

SKU: 32540 - 50 µg Category:

Description

(±)12-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 12(S)-HEPE and 12(R)-HEPE. The biological activity of (±)12-HEPE is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet aggregation with the same potency as 12-HETE, exhibiting IC50 values of 24 and 25 µM, respectively.{11169} These compounds are also equipotent as inhibitors of U46619-induced contraction of rat aorta (IC50s = 8.6-8.8 µM).{7481}


Formal name: (±)-12-hydroxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid

Synonyms: 

Molecular weight: 318.5

CAS: 81187-21-5

Purity: ≥98%

Formulation: A solution in ethanol